Daewoong Co., Ltd.

KSE 003090.KS

Daewoong Co., Ltd. Receivables for the year ending December 31, 2023: USD 130.69 M

Daewoong Co., Ltd. Receivables is USD 130.69 M for the year ending December 31, 2023, a -28.54% change year over year. Receivables are the amounts owed to the company by customers for goods sold or services rendered.

Daewoong Co., Ltd. Receivables for the year ending December 31, 2022 was USD 182.89 M, a 12.50% change year over year.
Daewoong Co., Ltd. Receivables for the year ending December 31, 2021 was USD 162.57 M, a -1.16% change year over year.
Daewoong Co., Ltd. Receivables for the year ending December 31, 2020 was USD 164.47 M, a -17.02% change year over year.
Daewoong Co., Ltd. Receivables for the year ending December 31, 2019 was USD 198.21 M, a 12.94% change year over year.

Key data

Date	Receivables	Inventory	Goodwill	Total Assets

KSE: 003090.KS

Daewoong Co., Ltd.

CEO	Mr. Yeong-Hwan Yoon
IPO Date	Jan. 4, 2000
Location	South Korea
Headquarters	35-14, Jajanggongdan 4-gil
Employees	353
Sector	Healthcare
Industries Pharmaceuticals Drugstores & Retail Pharmacies Eyewear

Description

Daewoong Co., Ltd., together with its subsidiaries, manufactures and sells pharmaceuticals. It also engages in the leasing of real estates. The company was formerly known as Daewoong Pharmaceutical Co., Ltd. and changed its name to Daewoong Co., Ltd. in 2002. Daewoong Co., Ltd. was founded in 1961 and is headquartered in Seongnam-si, South Korea.

Key trends

Past 5 years